Quarry LP’s Verona Pharma VRNA Stock Holding History

Quarry LP’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-99,300	Closed	-$10.6M	–	2662
2025 Q3	$10.6M	Buy	99,300 +97,600	+5,741%	+$10.2M	2.32%	5
2025 Q2	$161K	Sell	1,700 -100	-6%	-$7.4K	0.03%	406
2025 Q1	$114K	Buy	+1,800	New	+$108K	0.02%	471
2024 Q3	–	Sell	-2,000	Closed	-$28.9K	–	2104
2024 Q2	$28.9K	Sell	2,000 -3,500	-64%	-$51.1K	0.01%	932
2024 Q1	$88.5K	Buy	+5,500	New	+$95.1K	0.02%	261

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Quarry LP's VRNA Position: Q4 2025 in Review

Quarry LP sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 99,300 shares — an estimated $10.6M sold.

Quarry LP first reported a position in VRNA in Q1 2024 and held it in 5 quarters. The position peaked at $10.6M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Quarry LP reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Quarry LP sold 99,300 Verona Pharma shares in Q4 2025, an estimated $10.6M.
Quarry LP first reported a position in Verona Pharma in Q1 2024 and held it in 5 quarters.
Quarry LP's Verona Pharma position peaked at $10.6M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Quarry LP's 13F filing for Q4 2025, filed 13 Feb 2026.